These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16915301)

  • 21. Eplerenone. Pharmacia.
    Liew D; Martin J; Krum H
    Curr Opin Investig Drugs; 2003 Mar; 4(3):316-22. PubMed ID: 12744223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Insight: eplerenone, a mineralocorticoid-receptor antagonist.
    McManus F; McInnes GT; Connell JM
    Nat Clin Pract Endocrinol Metab; 2008 Jan; 4(1):44-52. PubMed ID: 18084345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [More benefit in hypertension and high-grade reduction of the pump performance. Earlier beginning of therapy maximizes the benefit].
    MMW Fortschr Med; 2004 Oct; 146(43):59. PubMed ID: 15559525
    [No Abstract]   [Full Text] [Related]  

  • 24. Mineralocorticoid receptor antagonists: their use and differentiation in Japan.
    Sato A
    Hypertens Res; 2013 Mar; 36(3):185-90. PubMed ID: 23171954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Eplerenone in resistant hypertension with previous spironolactone intolerance].
    Antonio Costa J; Rodilla E; Pérez-Lahiguera F; María Pascual J
    Med Clin (Barc); 2009 May; 132(19):756-7. PubMed ID: 19243793
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of aldosterone receptor blockade in the management of cardiovascular disease.
    Liew D; Krum H
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1468-73. PubMed ID: 12431020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of the RALES trial: good news for patients with heart failure and ... for health administrations].
    Azpitarte Almagro J
    Med Clin (Barc); 2000 Apr; 114(14):545-50. PubMed ID: 10846668
    [No Abstract]   [Full Text] [Related]  

  • 28. [Eplerenone for treatment of heart failure].
    Yoshimura M
    Nihon Rinsho; 2007 May; 65 Suppl 5():153-8. PubMed ID: 17569313
    [No Abstract]   [Full Text] [Related]  

  • 29. Mineralocorticoid-receptor blockade, hypertension and heart failure.
    Funder JW
    Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):4-5. PubMed ID: 16929357
    [No Abstract]   [Full Text] [Related]  

  • 30. Eplerenone in mild heart failure.
    Pascual-Figal DA; Sanchez-Mas J; Januzzi JL
    N Engl J Med; 2011 Apr; 364(14):1370; author reply 1372. PubMed ID: 21470020
    [No Abstract]   [Full Text] [Related]  

  • 31. [Eplerenone Post-AMI Heart Failure Efficacy and survival study (EPHESUS)].
    Takata Y; Asano K; Yamashina A
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():336-41. PubMed ID: 15813091
    [No Abstract]   [Full Text] [Related]  

  • 32. Eplerenone.
    Brown R; Quirk J; Kirkpatrick P
    Nat Rev Drug Discov; 2003 Mar; 2(3):177-8. PubMed ID: 12619638
    [No Abstract]   [Full Text] [Related]  

  • 33. Eplerenone in mild heart failure.
    Dastidar AG
    N Engl J Med; 2011 Apr; 364(14):1371-2; author reply 1372. PubMed ID: 21470017
    [No Abstract]   [Full Text] [Related]  

  • 34. [REMINDER Study: myocardial infarct without heart failure: does eplerenone have an advantage?].
    Overbeck P
    MMW Fortschr Med; 2013 Mar; 155 Spec No 1(1):20. PubMed ID: 24260911
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
    MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524
    [No Abstract]   [Full Text] [Related]  

  • 36. Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure.
    Ajani AE; Marwick TH; Krum H
    Cardiovasc Revasc Med; 2006; 7(4):234-6. PubMed ID: 17174870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is eplerenone nephrotoxic?].
    Krämer B
    Dtsch Med Wochenschr; 2012 Nov; 137(45):2340. PubMed ID: 23070799
    [No Abstract]   [Full Text] [Related]  

  • 38. Aldosterone target organ protection by eplerenone.
    Rudolph AE; Rocha R; McMahon EG
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):229-38. PubMed ID: 15134822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of aldosterone receptor blockers in the treatment of hypertension.
    Weinberger MH
    J Clin Hypertens (Greenwich); 2004 Nov; 6(11):632-5. PubMed ID: 15538096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost Effectiveness of Eplerenone for the Treatment of Systolic Heart Failure with Mild Symptoms in Alberta, Canada.
    Thanh NX; Ezekowitz JA; Tran DT; Kaul P
    Am J Cardiovasc Drugs; 2016 Oct; 16(5):365-76. PubMed ID: 27300508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.